Substance / Medication

Rimexolone

Overview

Active Ingredient
rimexolone
RxNorm CUI
55681

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

3 trials linked to this intervention

3
Total Trials
0
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Non-invasive Instrument-Based Tests for Quantifying Anterior Chamber Flare in Uveitis: A Systematic Review.
Liu Xiaoxuan, McNally Thomas W, Beese Sophie et al. · Ocul Immunol Inflamm · 2021
PMID: 32255392Meta-Analysis
The LMP2 CfoI polymorphism is associated with ankylosing spondylitis (AS) risk but not with acute anterior uveitis (AAU): A meta-analysis.
Qian Yufeng, Chen Bingqian, Sheng Xiaowen et al. · Medicine (Baltimore) · 2019
PMID: 31702633Meta-AnalysisFull text (PMC)
Clinical Features and Complications of the HLA-B27-associated Acute Anterior Uveitis: A Metanalysis.
D'Ambrosio Enzo Maria, La Cava Maurizio, Tortorella Paolo et al. · Semin Ophthalmol · 2017
PMID: 27404944Meta-Analysis
Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis: A systematic literature review.
Gómez-Gómez Alejandro, Loza Estíbaliz, Rosario Maria Piedad et al. · Medicine (Baltimore) · 2017
PMID: 29049193Meta-AnalysisFull text (PMC)
Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis.
Pato Esperanza, Muñoz-Fernández Santiago, Francisco Félix et al. · Semin Arthritis Rheum · 2011
PMID: 20656330Meta-Analysis
Efficacy and safety of 1% rimexolone versus 1% prednisolone acetate in the treatment of anterior uveitis--a randomized triple masked study.
Biswas Jyotirmay, Ganeshbabu T M, Raghavendran S Ramesh et al. · Int Ophthalmol · 2004
PMID: 15847313Trial
Ocular-hypertensive and anti-inflammatory response to rimexolone therapy in children.
Fan Dorothy S P, Yu Christopher B O, Chiu Thomas Y H et al. · Arch Ophthalmol · 2003
PMID: 14662591Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Rimexolone (substance)
SNOMED CT
387046003
UMLS CUI
C0140594
RxNorm CUI
55681

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
3
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.